罗欣药业: 第五届董事会第二十五次会议决议公告

Group 1 - The board of directors held its 25th meeting, which was legally convened and attended by all five directors [1][2] - The board approved the proposal to appoint Mr. Zuo Min as an independent director, pending approval from the shareholders' meeting [2][3] - The board agreed to adjust the special committee members, with Mr. Zuo Min set to join the Strategic Committee and Compensation and Assessment Committee after his appointment [3][4] Group 2 - The board proposed to amend the company's articles of association to reduce the number of board members from six to five [4][5] - The board scheduled the third extraordinary general meeting of shareholders for July 16, 2025, to discuss the proposed changes [5]